# A Study of ALS-008176 in Infants Hospitalized With RSV

> **NCT02202356** · PHASE1 · COMPLETED · sponsor: **Alios Biopharma Inc.** · enrollment: 183 (actual)

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** ALS-008176
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02202356
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-23
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-02-15
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202356, "A Study of ALS-008176 in Infants Hospitalized With RSV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02202356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*